These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 24336060)

  • 1. Methods for a systematic review of pneumococcal conjugate vaccine dosing schedules.
    Loo JD; Conklin L; Deloria Knoll M; Fleming-Dutra KE; Park DE; Kirk J; Johnson TS; Goldblatt D; O'Brien KL; Whitney CG
    Pediatr Infect Dis J; 2014 Jan; 33 Suppl 2(Suppl 2 Optimum Dosing of Pneumococcal Conjugate Vaccine For Infants 0 A Landscape Analysis of Evidence Supportin g Different Schedules):S182-7. PubMed ID: 24336060
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systematic review of the indirect effect of pneumococcal conjugate vaccine dosing schedules on pneumococcal disease and colonization.
    Loo JD; Conklin L; Fleming-Dutra KE; Knoll MD; Park DE; Kirk J; Goldblatt D; O'Brien KL; Whitney CG
    Pediatr Infect Dis J; 2014 Jan; 33 Suppl 2(Suppl 2 Optimum Dosing of Pneumococcal Conjugate Vaccine For Infants 0 A Landscape Analysis of Evidence Supportin g Different Schedules):S161-71. PubMed ID: 24336058
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systematic review of the effect of pneumococcal conjugate vaccine dosing schedules on vaccine-type nasopharyngeal carriage.
    Fleming-Dutra KE; Conklin L; Loo JD; Knoll MD; Park DE; Kirk J; Goldblatt D; Whitney CG; O'Brien KL
    Pediatr Infect Dis J; 2014 Jan; 33 Suppl 2(Suppl 2 Optimum Dosing of Pneumococcal Conjugate Vaccine For Infants 0 A Landscape Analysis of Evidence Supportin g Different Schedules):S152-60. PubMed ID: 24336057
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systematic review of the effect of pneumococcal conjugate vaccine dosing schedules on vaccine-type invasive pneumococcal disease among young children.
    Conklin L; Loo JD; Kirk J; Fleming-Dutra KE; Deloria Knoll M; Park DE; Goldblatt D; O'Brien KL; Whitney CG
    Pediatr Infect Dis J; 2014 Jan; 33 Suppl 2(Suppl 2 Optimum Dosing of Pneumococcal Conjugate Vaccine For Infants 0 A Landscape Analysis of Evidence Supportin g Different Schedules):S109-18. PubMed ID: 24336053
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dosing schedules for pneumococcal conjugate vaccine: considerations for policy makers.
    Whitney CG; Goldblatt D; O'Brien KL
    Pediatr Infect Dis J; 2014 Jan; 33 Suppl 2(Suppl 2 Optimum Dosing of Pneumococcal Conjugate Vaccine For Infants 0 A Landscape Analysis of Evidence Supportin g Different Schedules):S172-81. PubMed ID: 24336059
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systematic review of the effect of pneumococcal conjugate vaccine dosing schedules on prevention of pneumonia.
    Loo JD; Conklin L; Fleming-Dutra KE; Deloria Knoll M; Park DE; Kirk J; Goldblatt D; O'Brien KL; Whitney CG
    Pediatr Infect Dis J; 2014 Jan; 33 Suppl 2(Suppl 2 Optimum Dosing of Pneumococcal Conjugate Vaccine For Infants 0 A Landscape Analysis of Evidence Supportin g Different Schedules):S140-51. PubMed ID: 24336056
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of reduced-dose schedules with 7-valent pneumococcal conjugate vaccine on nasopharyngeal pneumococcal carriage in children: a randomized controlled trial.
    van Gils EJ; Veenhoven RH; Hak E; Rodenburg GD; Bogaert D; Ijzerman EP; Bruin JP; van Alphen L; Sanders EA
    JAMA; 2009 Jul; 302(2):159-67. PubMed ID: 19584345
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pneumococcal vaccination in Europe: schedule adherence.
    Gervaix A; Ansaldi F; Brito-Avô A; Azzari C; Knuf M; Martinón-Torres F; Tuerlinckx D; Tin Htar MT; Syrogiannopoulos GA
    Clin Ther; 2014 May; 36(5):802-12.e1. PubMed ID: 24746990
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Indirect (herd) protection, following pneumococcal conjugated vaccines introduction: A systematic review of the literature.
    Tsaban G; Ben-Shimol S
    Vaccine; 2017 May; 35(22):2882-2891. PubMed ID: 28449971
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunogenicity and Reactogenicity of 13-Valent Pneumococcal Conjugate Vaccine Among Infants, Toddlers, and Children in Western Burkina Faso: Results From a Clinical Trial of Alternative Immunization Schedules.
    Moïsi JC; Yaro S; Kroman SS; Gouem C; Bayane D; Ganama S; Meda B; Nacro B; Njanpop-Lafourcade BM; Ouangraoua S; Ouedraogo I; Sakande S; Sawadogo F; Zida S; Ouedraogo JB; Gessner BD
    J Pediatric Infect Dis Soc; 2019 Nov; 8(5):422-432. PubMed ID: 30299491
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of Pneumococcal Conjugate Vaccine Administration in Pediatric Older Age Groups in Low and Middle Income Countries: A Systematic Review.
    Bonner K; Welch E; Elder K; Cohn J
    PLoS One; 2015; 10(8):e0135270. PubMed ID: 26332848
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adherence to pneumococcal conjugate vaccination schedule and uptake rate as compared to the established diphtheria-tetanus-acellular pertussis vaccination in Cyprus.
    Hadjipanayis A; Efstathiou E; Michaelidou K; Papaevangelou V
    Vaccine; 2018 Sep; 36(38):5685-5691. PubMed ID: 30115523
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systematic review of the effect of pneumococcal conjugate vaccine dosing schedules on immunogenicity.
    Deloria Knoll M; Park DE; Johnson TS; Chandir S; Nonyane BA; Conklin L; Fleming-Dutra KE; Loo JD; Goldblatt D; Whitney CG; O'Brien KL
    Pediatr Infect Dis J; 2014 Jan; 33 Suppl 2(Suppl 2 Optimum Dosing of Pneumococcal Conjugate Vaccine For Infants 0 A Landscape Analysis of Evidence Supportin g Different Schedules):S119-29. PubMed ID: 24336054
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost Effectiveness of Pneumococcal Vaccination in Children in Low- and Middle-Income Countries: A Systematic Review.
    Saokaew S; Rayanakorn A; Wu DB; Chaiyakunapruk N
    Pharmacoeconomics; 2016 Dec; 34(12):1211-1225. PubMed ID: 27510721
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evolving role of 13-valent pneumococcal conjugate vaccine in clinical practice.
    Azzari C; Martinón-Torres F; Schmitt HJ; Dagan R
    Pediatr Infect Dis J; 2014 Aug; 33(8):858-64. PubMed ID: 24618937
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The short-term impact of each primary dose of pneumococcal conjugate vaccine on nasopharyngeal carriage: Systematic review and meta-analyses of randomised controlled trials.
    Nicholls TR; Leach AJ; Morris PS
    Vaccine; 2016 Feb; 34(6):703-13. PubMed ID: 26742947
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A current and historical perspective on disparities in US childhood pneumococcal conjugate vaccine adherence and in rates of invasive pneumococcal disease: Considerations for the routinely-recommended, pediatric PCV dosing schedule in the United States.
    McLaughlin JM; Utt EA; Hill NM; Welch VL; Power E; Sylvester GC
    Hum Vaccin Immunother; 2016; 12(1):206-12. PubMed ID: 26376039
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dose-specific Effectiveness of 7- and 13-Valent Pneumococcal Conjugate Vaccines Against Vaccine-serotype Streptococcus pneumoniae Colonization in Children.
    Lewnard JA; Givon-Lavi N; Dagan R
    Clin Infect Dis; 2020 Nov; 71(8):e289-e300. PubMed ID: 31784753
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparing pneumococcal conjugate vaccine schedules based on 3 and 2 primary doses: systematic review and meta-analysis.
    Scott P; Rutjes AW; Bermetz L; Robert N; Scott S; Lourenço T; Egger M; Low N
    Vaccine; 2011 Dec; 29(52):9711-21. PubMed ID: 21821080
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and Effectiveness of the PCV-10 and PCV-13 Vaccines Against Invasive Pneumococcal Disease.
    Berman-Rosa M; O'Donnell S; Barker M; Quach C
    Pediatrics; 2020 Apr; 145(4):. PubMed ID: 32156773
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.